Fast Company March 21, 2023
When the COVID-19 public health emergency ends in May, some patients will face new hurdles to the telemedicine services they’ve relied on for three years.
Over the past few weeks, desperate messages have been pouring into the telehealth company Boulder Care from patients who say a new proposed rule by the federal government could put their health—and their lives—at risk.
The rule, proposed by the Drug Enforcement Agency (DEA), would require anyone being prescribed certain controlled substances via telemedicine to see a doctor in person in order to continue their care online. That includes drugs like buprenorphine, which Boulder Care’s providers use to treat people with opioid use disorder, but also testosterone therapy for transgender people, Adderall prescriptions...
Today's Sponsors
Today's Sponsor
Topics: CMS, Digital Health, Govt Agencies, HHS, Patient / Consumer, Provider, Technology, Telehealth